New eye gel aims to take the sting out of Vision-Saving injections
NCT ID NCT07456826
Summary
This study is testing if a new numbing gel (chloroprocaine) works as well as the current standard method (eye drops plus a small injection) to reduce pain during eye injections for conditions like macular degeneration and diabetic eye disease. About 236 adults who regularly get these injections will be randomly assigned to receive either the new gel or the standard method. The main goal is to see if the gel provides similar pain relief, and researchers will also check for side effects and changes in dry eye symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY, DR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tyler Retina Research Institute
RECRUITINGTyler, Texas, 75703, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.